28,718$ (139,489)Basic and diluted net income (loss)per common share$
(0.05) Balance Sheet HighlightsMarch 31, 2013June 30, 2012Cash and cash equivalents
278,263Trade accounts receivable3,633,2473,667,086Inventories, net6,187,5626,098,597Total current assets10,693,62810,654,158Total assets
5,270,930Line of credit
3,497,597Accounts payable2,032,5972,413,201Accrued expenses270,080386,229Total current liabilities7,024,0337,088,300Total liabilities8,666,5249,004,615Total liabilities and equity
5,270,930Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www.dynatronics.com.
This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements such as the statement regarding expectations for future new product introductions and plans to expand distribution. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost-ef
|SOURCE Dynatronics Corporation|
Copyright©2012 PR Newswire.
All rights reserved